ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,629, issued on March 24, was assigned to Innovate Therapeutics LLC (Princeton, N.J.).
"Extended-release pharmaceutical compositions of Ralinepag" was invented by Danielle Marie Le Roux (West Milford, N.J.) and Jayendrakumar Dasharathlal Patel (Robbinsville, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to extended-release pharmaceutical compositions comprising Ralinepag or a pharmaceutically acceptable salt, solvate, or prodrug thereof, formulated for low-dose oral administration to provide controlled release of the active ingredient over about 8 to 24 hours. The compositions comprise Ralinepag in an amount from ...